HIV Prevention
Studies include:
- Phase 3 efficacy trial of monthly oral PrEP in African women (EXPrESSIVE-10), in partnership with Merck, MSD, and Gates Foundation (EXPrESSIVE Study, Celum, PI)
- Adherence efficacy relationships for tenofovir-based PrEP in African women; (Benchmark study, Mugwanya, PI)
Tuberculosis (TB)
Studies include:
- HIV PrEP among people with TB in Uganda (TB PrEP, Ross, PI)
- New pathways to prevention from community TB screening in South Africa (ThiPhiSA Study, Shapiro, PI)
STI Prevention
Studies include:
- Bexsero meningococcal B vaccine for GC prevention among South African women (Biyela study, Celum PI)
- Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected persons (DoxyPEP and DoxyImpact studies, Celum, PI)
POC Diagnostics
Content to be determined
One Health
Studies include:
- Disease transmission along complex human-animal networks: a novel method for improving zoonotic disease modeling (CHAIN Study, Meisner, PI)
- US-Israel Collab: A structural and multiepistemic approach to modeling Brucella transmission along complex networks in Bedouin communities (BRUCE Study, Meisner, PI)
Refugee Health
Studies include:
- Head StART Study (O’Laughlin, PI)
Molecular Mechanisms for Susceptibility to HIV
Studies include:
- The push and pull of inflammation on HIV susceptibility: impact of host variation in CD101 and AXL (Push/Pull Study, Lingappa, PI)
Content to be determined